Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Unlabelled: High-throughput functional assays measure the effects of variants on macromolecular function and can aid in reclassifying the rapidly growing number of variants of uncertain significance. Under the current clinical variant classification guidelines, using functional data as a line of evidence to assert pathogenicity relies on determining assay score thresholds that define variants as functionally normal or functionally abnormal. These thresholds are designed to maximize the separation of variants with known clinical effects (benign, pathogenic) and often incorporate expert opinion. However, this approach lacks the rigor of calibration, in which a variant's posterior probability of pathogenicity must be estimated from the raw experimental score and mapped to discrete evidence strengths. To build upon the existing guidelines, we introduce and evaluate a method for calibrating continuous high-throughput functional data as a line of evidence in clinical variant classification. Assay score distributions of synonymous variants and variants appearing in gnomAD for a given functional scoreset are jointly modeled with score distributions of known pathogenic and benign variants using a multi-sample skew normal mixture of distributions. This model is learned using a constrained expectation-maximization algorithm that provably preserves the monotonicity of pathogenicity posteriors and is subsequently used to calculate variant-specific evidence strengths for use in the clinic. Using 24 datasets from 14 genes, we first assess the model's ability to capture assay score distributions. We then demonstrate its potential impact on reclassifying variants by comparing the evidence strengths assigned at the variant-level with those assigned uniformly to all functionally normal and abnormal variants under the existing ClinGen guidelines. An improved classification of variants will directly improve the accuracy of genetic diagnosis and subsequent medical management for individuals affected by Mendelian disorders.

Availability: https://github.com/dzeiberg/mave_calibration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12248162PMC
http://dx.doi.org/10.1101/2025.04.29.651326DOI Listing

Publication Analysis

Top Keywords

high-throughput functional
12
clinical variant
12
variant classification
12
assay score
12
evidence strengths
12
score distributions
12
variants
10
functional assays
8
functional data
8
data evidence
8

Similar Publications

CRISPR technologies are rapidly transforming agriculture by enabling precise and programmable modifications across a wide range of organisms. This review provides an overview of CRISPR applications in crops, livestock, aquaculture, and microbial systems, highlighting key advances in sustainable agriculture. In crops, CRISPR has accelerated the improvement of traits such as drought tolerance, nutrient efficiency, and pathogen resistance.

View Article and Find Full Text PDF

Purpose: Next-generation sequencing (NGS) has revolutionized cancer treatment by enabling comprehensive cancer genomic profiling (CGP) to guide genotype-directed therapies. While several prospective trials have demonstrated varying outcomes with CGP in patients with advanced solid tumors, its clinical utility in colorectal cancer (CRC) remains to be evaluated.

Methods: We conducted a prospective observational study of CGP in our hospital between September 2019 and March 2024.

View Article and Find Full Text PDF

Low-cost and high-throughput RNA sequencing data for barley RILs achieved GP performance comparable to or better than traditional SNP array datasets when combined with parental whole-genome sequencing SNP data. The field of genomic selection (GS) is advancing rapidly on many fronts including the utilization of multi-omics datasets with the goal of increasing prediction ability and becoming an integral part of an increasing number of breeding programs ensuring future food security. In this study, we used RNA sequencing (RNA-Seq) data to perform genomic prediction (GP) on three related barley RIL populations.

View Article and Find Full Text PDF

Molecular subtypes of human skeletal muscle in cancer cachexia.

Nature

September 2025

Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Cancer-associated muscle wasting is associated with poor clinical outcomes, but its underlying biology is largely uncharted in humans. Unbiased analysis of the RNAome (coding and non-coding RNAs) with unsupervised clustering using integrative non-negative matrix factorization provides a means of identifying distinct molecular subtypes and was applied here to muscle of patients with colorectal or pancreatic cancer. Rectus abdominis biopsies from 84 patients were profiled using high-throughput next-generation sequencing.

View Article and Find Full Text PDF

Precise measurement of motor neuron dysfunction in Drosophila ALS model via climbing assay and leg imaging.

Methods Cell Biol

September 2025

The HIT Center for Life Sciences, Harbin Institute of Technology, Harbin, P.R. China; Medical and Health Research Institute, Zhengzhou Research Institute of HIT, Zhengzhou, HA, P.R. China. Electronic address:

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disorder characterized by progressive degeneration of motor neurons, leading to muscle weakness, paralysis, and death. While there is a plethora of studies focusing on many aspects of ALS, the pathogenesis of this disease is not well understood, and effective treatments are scarce. Drosophila melanogaster is a powerful model organism for studying ALS due to its genetic tractability and its evolutionarily conserved cellular and molecular processes which are also shared between the fly and human.

View Article and Find Full Text PDF